AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 72 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $6,000 | 0.0% | 823 | 0.0% | 0.00% | – |
Q3 2019 | $6,000 | -57.1% | 823 | -61.0% | 0.00% | – |
Q2 2019 | $14,000 | -91.1% | 2,110 | -86.8% | 0.00% | -100.0% |
Q1 2018 | $158,000 | +83.7% | 15,972 | 0.0% | 0.00% | – |
Q4 2017 | $86,000 | +48.3% | 15,972 | +31.0% | 0.00% | – |
Q3 2017 | $58,000 | +1.8% | 12,191 | -17.7% | 0.00% | – |
Q2 2017 | $57,000 | – | 14,814 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $532,000 | 6.17% |
Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |